The Allstate Corporation

NYSE:ALL Stock Report

Market Cap: US$52.1b

Allstate Valuation

Is ALL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ALL ($196.88) is trading below our estimate of fair value ($506.86)

Significantly Below Fair Value: ALL is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALL?

Key metric: As ALL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ALL. This is calculated by dividing ALL's market cap by their current earnings.
What is ALL's PE Ratio?
PE Ratio12.7x
EarningsUS$4.11b
Market CapUS$52.13b

Price to Earnings Ratio vs Peers

How does ALL's PE Ratio compare to its peers?

The above table shows the PE ratio for ALL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average10.7x
TRV Travelers Companies
13.1x2.6%US$59.2b
HIG Hartford Financial Services Group
11.4x7.7%US$34.2b
ACGL Arch Capital Group
6.7x-14.5%US$38.2b
CB Chubb
11.6x1.0%US$116.1b
ALL Allstate
12.7x5.0%US$52.1b

Price-To-Earnings vs Peers: ALL is expensive based on its Price-To-Earnings Ratio (12.7x) compared to the peer average (10.7x).


Price to Earnings Ratio vs Industry

How does ALL's PE Ratio compare vs other companies in the US Insurance Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
1.9xn/aUS$85.49m
AORE.F American Overseas Group
2.1xn/aUS$16.68m
CUII China United Insurance Service
0.0003xn/aUS$3.13k
No more companies available in this PE range
ALL 12.7xIndustry Avg. 13.1xNo. of Companies14PE01020304050+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ALL is good value based on its Price-To-Earnings Ratio (12.7x) compared to the US Insurance industry average (13.1x).


Price to Earnings Ratio vs Fair Ratio

What is ALL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.7x
Fair PE Ratio14.9x

Price-To-Earnings vs Fair Ratio: ALL is good value based on its Price-To-Earnings Ratio (12.7x) compared to the estimated Fair Price-To-Earnings Ratio (14.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$196.88
US$218.50
+11.0%
13.6%US$267.00US$138.00n/a16
Nov ’25US$184.15
US$211.69
+15.0%
13.1%US$272.00US$138.00n/a16
Oct ’25US$189.88
US$200.67
+5.7%
10.2%US$226.00US$138.00n/a18
Sep ’25US$188.94
US$198.24
+4.9%
10.1%US$226.00US$130.00n/a17
Aug ’25US$177.38
US$191.41
+7.9%
11.5%US$226.00US$130.00n/a17
Jul ’25US$160.54
US$189.06
+17.8%
10.2%US$213.00US$130.00n/a17
Jun ’25US$167.52
US$186.22
+11.2%
11.6%US$213.00US$130.00n/a18
May ’25US$171.56
US$180.21
+5.0%
12.1%US$206.00US$130.00n/a19
Apr ’25US$172.57
US$176.16
+2.1%
12.5%US$209.00US$122.00n/a19
Mar ’25US$155.15
US$169.89
+9.5%
11.7%US$196.00US$122.00n/a19
Feb ’25US$156.19
US$161.68
+3.5%
12.3%US$193.00US$112.00n/a19
Jan ’25US$139.98
US$143.06
+2.2%
10.9%US$165.00US$106.00n/a18
Dec ’24US$137.68
US$138.67
+0.7%
11.5%US$160.00US$106.00n/a17
Nov ’24US$129.75
US$130.85
+0.8%
12.3%US$156.00US$100.00US$184.1517
Oct ’24US$111.41
US$128.26
+15.1%
11.5%US$154.00US$100.00US$189.8817
Sep ’24US$110.56
US$127.59
+15.4%
11.9%US$154.00US$100.00US$188.9417
Aug ’24US$113.03
US$129.71
+14.8%
13.2%US$162.00US$100.00US$177.3817
Jul ’24US$109.04
US$133.94
+22.8%
11.6%US$157.00US$100.00US$160.5416
Jun ’24US$109.20
US$136.80
+25.3%
11.4%US$157.00US$100.00US$167.5215
May ’24US$115.86
US$139.94
+20.8%
13.0%US$176.00US$100.00US$171.5616
Apr ’24US$110.81
US$141.50
+27.7%
12.2%US$176.00US$104.00US$172.5716
Mar ’24US$127.61
US$144.19
+13.0%
11.9%US$176.00US$104.00US$155.1516
Feb ’24US$128.16
US$145.56
+13.6%
11.8%US$176.00US$105.00US$156.1916
Jan ’24US$135.60
US$142.47
+5.1%
13.5%US$188.00US$100.00US$139.9815
Dec ’23US$132.01
US$141.63
+7.3%
13.0%US$188.00US$100.00US$137.6816
Nov ’23US$125.75
US$139.81
+11.2%
13.9%US$188.00US$100.00US$129.7516

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies